Found 6 matching trials
A Phase 2b Study to Evaluate Rezpegaldesleukin (Rezpeg) in the Treatment of Adult Patients With Moderate-to-Severe Atopic Dermatitis
PHASE2This is an interventional, randomized, parallel group, treatment, Phase IIb...
Status
Active Not Recruiting
Location
Nektar Investigative Site
A Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic Dermatitis
PHASE3This is an interventional, randomized, parallel group, treatment, Phase 3, ...
Location
Nektar Investigative Site
A Phase 2b Study to Evaluate Rezpegaldesleukin (Rezpeg) in the Treatment of Severe to Very Severe Alopecia Areata in Adult Patients (Rezolve AA)
PHASE2This is an interventional, randomized, double blind, parallel group, placeb...
Status
Active Not Recruiting
Location
Nektar Investigative Site
A Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic Dermatitis
PHASE3This is an interventional, randomized, parallel group, treatment, Phase 3, ...
Location
Nektar Investigative Site
Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus
PHASE2This Phase 2 study is a 2-arm, multi-center, double-masked (masking of the ...
Location
Barbara Davis Center for Diabetes
A Study of LY3471851 in Adults With Systemic Lupus Erythematosus (SLE)
PHASE2The reason for this study is to see if the study drug LY3471851 (NKTR-358) ...
Location
University of California - San Diego